Northern Trust’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,713
Closed -$27.6K 4509
2025
Q4
$27.6K Buy
+12,713
New +$51.7K ﹤0.01% 4360
2024
Q3
Sell
-23,315
Closed -$137K 4443
2024
Q2
$137K Sell
23,315
-2,178
-9% -$19.5K ﹤0.01% 3972
2024
Q1
$231K Buy
25,493
+5,920
+30% +$70.6K ﹤0.01% 3844
2023
Q4
$215K Sell
19,573
-872
-4% -$9.72K ﹤0.01% 3877
2023
Q3
$362K Buy
20,445
+2,954
+17% +$108K ﹤0.01% 3606
2023
Q2
$960K Buy
17,491
+2,980
+21% +$190K ﹤0.01% 3380
2023
Q1
$988K Buy
14,511
+53
+0.4% +$4.12K ﹤0.01% 3225
2022
Q4
$876K Buy
14,458
+352
+2% +$32.7K ﹤0.01% 3311
2022
Q3
$1.42M Sell
14,106
-196
-1% -$22.8K ﹤0.01% 3179
2022
Q2
$1.26M Buy
14,302
+12,277
+606% +$1.5M ﹤0.01% 3276
2022
Q1
$307K Sell
2,025
-60
-3% -$11.2K ﹤0.01% 3937
2021
Q4
$664K Buy
+2,085
New +$735K ﹤0.01% 3703

Other funds holding RBOT

Northern Trust's RBOT Position: Q1 2026 in Review

Northern Trust sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 12,713 shares — an estimated $27.6K sold.

Northern Trust first reported a position in RBOT in Q4 2021 and held it in 12 quarters. The position peaked at $1.42M in Q3 2022. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Northern Trust reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 12,713 Vicarious Surgical shares in Q1 2026, an estimated $27.6K.
  • Northern Trust first reported a position in Vicarious Surgical in Q4 2021 and held it in 12 quarters.
  • Northern Trust's Vicarious Surgical position peaked at $1.42M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.